Research output per year
Research output per year
Fingerprint
Dive into the research topics where Daria Podlekareva is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Cognitive impairments among patients in a long-COVID clinic: Prevalence, pattern and relation to illness severity, work function and quality of life
Miskowiak, K. W., Pedersen, J. K., Gunnarsson, D. V., Roikjer, T. K., Podlekareva, D., Hansen, H., Dall, C. H. & Johnsen, S., 1 Mar 2023, In: Journal of Affective Disorders. 324, p. 162-169 8 p.Research output: Contribution to journal › Journal article › Research › peer-review
-
Treatment effect modifiers in hospitalised patients with COVID-19 receiving remdesivir and dexamethasone
Leding, C., Bodilsen, J., Brieghel, C., Harboe, Z. B., Helleberg, M., Holm, C., Israelsen, S. B., Jensen, J., Jensen, T. Ø., Johansen, I. S., Johnsen, S., Kirk, O., Lindegaard, B., Meyer, C. N., Mohey, R., Pedersen, L., Nielsen, H., Nielsen, S. L., Omland, L. H., Podlekareva, D., & 10 others, 11 Mar 2023, (E-pub ahead of print) In: Infectious diseases (London, England). p. 1-10 10 p.Research output: Contribution to journal › Journal article › Research › peer-review
-
Cerebral Metabolic Rate of Glucose and Cognitive Tests in Long COVID Patients
Miskowiak, K. W., Bech, J. L., Henriksen, A. C., Johnsen, S., Podlekareva, D. & Marner, L., 22 Dec 2022, In: Brain Sciences. 13, 1, 23.Research output: Contribution to journal › Journal article › Research › peer-review
-
Early stimulated immune responses predict clinical disease severity in hospitalized COVID-19 patients
Svanberg, R., MacPherson, C., Zucco, A., Agius, R., Faitova, T., Andersen, M. A., da Cunha-Bang, C., Gjærde, L. K., Møller, M. E. E., Brooks, P. T., Lindegaard, B., Sejdic, A., Gang, A. O., Hersby, D. S., Brieghel, C., Nielsen, S. D., Podlekareva, D., Hald, A., Bay, J. T., Marquart, H., & 5 others, 2022, In: Communications medicine. 2, p. 114Research output: Contribution to journal › Journal article › Research › peer-review
-
Hyperimmune immunoglobulin for hospitalised patients with COVID-19 (ITAC): a double-blind, placebo-controlled, phase 3, randomised trial
ITAC (INSIGHT 013) Study Group, Polizzotto, M. N., Nordwall, J., Babiker, A. G., Phillips, A., Vock, D. M., Eriobu, N., Khwaghe, V., Paredes, R., Mateu, L., Ramachandruni, S., Narang, R., Jain, M. K., Lazarte, S. M., Baker, J. V., Frosch, A. E. P., Poulakou, G., Syrigos, K. N., Arnoczy, G. S., Robinson, P. A., & 69 others, 5 Feb 2022, In: The Lancet. 399, 10324, p. 530-540 11 p.Research output: Contribution to journal › Journal article › Research › peer-review